Cohort profile: The Swiss Hepatitis C Cohort Study (SCCS)

International Journal of Epidemiology

Volumn 36, Issue 4, 2007, Pages 731-737

  Prasad, Leonie ^a   Spicher, Virginie Masserey ^b   Zwahlen, Marcel ^a   Rickenbach, Martin ^c   Helbling, Beat ^d   Negro, Francesco ^e  

^a Div of Epidemiol and Infect Dis   (Switzerland)

^b FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Stadtspital Waid   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON;

COHORT ANALYSIS; HEPATITIS;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LIVER BIOPSY; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SWITZERLAND;

ADULT; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SWITZERLAND;

CENTRAL EUROPE; EURASIA; EUROPE; SWITZERLAND;

HEPATITIS C VIRUS;

EID: 34548577147     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym096     Document Type: Article

References (16)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA done derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. World Health Organization, Hepatitis C Fact Sheet No. 164. 2000, WHO.
3. Ledergerber B, von Overbeck J, Egger M, Luthy R. The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristics. Soz Praventivmed 1994;39:387-94.
4. Egger M, Hirschel B, Francioli P et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. Br Med J 1997;315:1194-99.
5. Ledergerber B, Egger M, Erard V et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 1999;282:2220-26.
6. Ledergerber B, Egger M, Opravil M et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study. Lancet 1999;353:863-68.
7. Staehelin C, Rickenbach M, Low N et al. Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: Access to antiretroviral therapy, disease progression and survival. Aids 2003;17:2237-44.
8. Sterne JA, Hernan MA, Ledergerber B et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study. Lancet 2005;366:378-84.
9. Sudre P, Rickenbach M, Taffe P, Janin P, Volkart AC, Francioli P. Clinical epidemiology and research on HIV infection in Switzerland: The Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr 2000; 130:1493-500.
10. World Health Organization, International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2006: Available at: www3.who.int/icd/currentversion/fr-icd.htm
11. Roudot-Thoraval F, Bastie A, Pawlotsky J-M, Dhumeaux D. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients. Hepatology 1997;26:485-90.
12. Mohsen AH. Trent HCV Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 minion. Gut 2001;48 707-13.
13. Niederau C, Lange S, Heintges T et al. Prognosis of chronic hepatitis C: Results of a large, prospective cohort study. Hepatology 1998;28:1687-95.
14. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6 35-47.
15. National Institute for Clinical Excellence. Technology Appraisal 75. Interferon alfa (pegylated and non-pegylat) and ribavirin for the treatment of chronic hepatitis C., London: National Institute for Clinical Excellence, 2004. pp. 1-38.
16. Muzzi A, Leandro G, Rubbia-Brandt L et al. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 2005;42.41-46.